linsidomine has been researched along with Neurodegenerative Diseases in 2 studies
linsidomine: RN given refers to parent cpd; structure
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kupershmidt, L | 1 |
| Amit, T | 1 |
| Bar-Am, O | 1 |
| Youdim, MB | 1 |
| Blumenfeld, Z | 1 |
| Oh-hashi, K | 1 |
| Maruyama, W | 1 |
| Yi, H | 1 |
| Takahashi, T | 1 |
| Naoi, M | 1 |
| Isobe, K | 1 |
2 other studies available for linsidomine and Neurodegenerative Diseases
| Article | Year |
|---|---|
The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
Topics: Activins; Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Cell Line, Tumor; Cell Survival; | 2007 |
Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Caspase 3; Caspase Inhibitors | 1999 |